2025-04-19
5 分钟Hey, listeners, it's Saturday, April 19th.
I'm Francesca Fontana for the Wall Street Journal, and this is what's news in markets.
Our look at the biggest stock moves of the week and the news that drove them.
Let's get to it.
After some relative calm earlier in the week,
the tariff angst came for the chip industry on Wednesday and ended up weighing down tech stocks.
Also turning stocks lower was a warning from Fed Chair Jerome Powell,
who said there was a strong likelihood that the economy take a hit from President Trump's trade war.
The Dow was also dragged down Thursday by disappointing results from UnitedHealth,
with the Healthcare bellwether share price having an outsized effect on the price weighted index.
But more on that in a bit.
And Friday, as you likely noticed, the stock market was closed for good Friday.
On the week, the s and P 500 lost 1.5%, the Dow fell 2.7%, and the Nasdaq fell 2.6%.
First up, let's talk about some big movers outside of all the tariff drama, like Eli Lilly,
one of the drug makers vying for the weed in the race for a weight loss pill.
A little context.
Pharmaceutical companies including Lilly and Novo Nordisk,
which currently dominate the obesity market with injectable drugs like Zepbound and Wegovy,
have been testing pills that could help people lose weight.
The market for weight loss drugs has been on fire,